Eli Lilly | LLY - Credores Comerciais

Preço das Ações
886.19
Mudança Diária
2.23 0.25%
Mensal
-0.05%
Anual
1.01%
Q2 Previsão
865.04




Credores Comerciais Alterar Data
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.24B 117M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Baxter International USD 999M 46M 2025-12
Biogen USD 432M 18.9M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Coherus Biosciences USD 9.91M 14.98M 2025-12
Drreddys Laboratories INR 454.04M 854K 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Gilead Sciences USD 715M 93M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
J&J USD 10.46B 1.53B 2026-03
Medtronic USD 2.57B 12M 2025-12
Merck USD 4.15B 102M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Novartis USD 4.46B 99M 2025-12
Novo Nordisk DKK 19.76B 4.15B 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Phibro Animal Health USD 133.3M 2.7M 2025-12
Prestige Brands USD 42.95M 1.02M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Sanofi EUR 22.93B 2.89B 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Zoetis USD 487M 77M 2025-12